International Leaders in Clinical Trial Management
A dedicated Contract Research Organization serving the pharmaceutical and biotech industry.
Site Navigation
Links & Resources
About Trial Care International
TCI specializes in the management of Phase I-IV clinical trials in a wide range of therapeutic areas. We have learned from over a decade of experience in this field that the key to successful execution of clinical programs is listening to your needs, setting goals while defining lines of communication. Adaptability to change direction at any given time takes valiant leadership skills.
At TCI, we are committed to providing the highest level of therapeutic expertise possible for every trial we manage. This commitment is evident in the fundamental way that we do business, from project staffing to client communication.
TCI’s core team consists of senior experts with many years experience directing successful programs leading to FDA approvals. We have extensive expertise pertaining to trials utilizing imaging modalities such as PET/CT, MRI, CT and Ultrasound. In addition, we utilize a large pool of the most talented clinical research professionals, including those with many years of experience in specific therapeutic areas. We offer global reach through select partners throughout Europe and Asia. As a result, you can be confident that you are serviced by a team with the geographical locale, and clinical and regulatory expertise needed to achieve truly excellent results.
Over the years, our people have achieved extensive expertise managing and monitoring clinical trials in a number of key therapeutic areas. We have worked on drug, biologics, vaccines, diagnostics and device studies. We have specific expertise pertaining to radiopharmaceuticals and contrast agents. We have experience successfully managing Phase I-IV studies in the following areas:
|
|
Our team has specialized in imaging trials over the last fifteen years. We have been involved with writing the imaging and statistical sections of protocols, composing imaging and radiopharmacy manuals, developed imaging charters for core labs, facilitated and provided blinded reads and training. In addition, we have a pool of investigators, clinics, hospitals and universities with whom we have worked with over the years and can recommend for obtaining quality data.
We have been involved with several products managing pivotal studies through successful FDA approvals. Our experience involve radiopharmaceuticals for many different indications including PET/CT oncology studies and radiotherapeutics, MRI contrast agents, Iodinated contrast agents and Ultrasound contrast agents for oncology indications.
Many of our CRAs are certified in one or more imaging modality and are able to evaluate site’s imaging capabilities and equipment standards. We can also provide training and technical expertise to the sites throughout the study.